Skip to content
Recall Observatory FDA recall evidence

Drug product

Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031

D-0279-2019

November 06, 2018

Class III

Product summary

Firm
Breckenridge Pharmaceutical, Inc.
Event
Event 81523
Status
Terminated
Classification
Class III
Quantity
9,193 bottles
Official record key
drug-enforcement:D-0279-2019

Official wording

Reason: Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Code information: Lot #: 5599.008A, 5599.009A, 5599.010A, Exp. 04/2019; 5599.012A, 5599.013A, Exp. 11/2019; 5599.014A, Exp. 01/2020

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-Specification